Draft Evidence Report
New England CEPAC

PDF cover

Hemophilia A: Draft Evidence Report

ICER’s Draft Evidence Report on emicizumab for hemophilia A, open to public comment until February 23, 2018 at 5pm ET. For more information on submitting a public comment, visit our engagement page.

View

View All Materials on this Topic or Go Back to View More Materials